#health policy

Republican-led states are moving beyond federal cooperation requirements by directing health agencies to report some Medicaid recipients to immigration authorities, a shift researchers say could spread and reshape howimm

The Supreme Court rejected a challenge to Medicare drug price negotiation, a move that could make the pharmaceutical industry’s remaining lawsuits harder to win.

STAT reports that acting FDA drug center head Tracy Beth Høeg is leaving the agency, widening a leadership vacuum that followed Commissioner Marty Makary’s resignation.

Sen. Bill Cassidy, a prominent health lawmaker, is set to lose his seat after Louisiana’s Republican primary sent the race to a runoff between state treasurer John Fleming and Trump-backed Rep. Julia Letlow.

Candidate metadata indicates President Donald Trump is attacking Sen. Bill Cassidy as disloyal while backing a challenger, turning a Louisiana Republican primary into a contest with implications for federal health policy

Endpoints News identified Marty Makary’s resignation as the week’s biggest health story, underscoring how quickly leadership changes at the FDA can dominate the sector’s outlook.

The Supreme Court preserved current mail access to mifepristone for now, leaving existing distribution protocols in place while litigation continues.

The head of the FDA’s drug division, Tracy Beth Høeg, is expected to leave the agency following the recent exit of Commissioner Marty Makary, according to a source familiar with the matter.

Researchers from leading UK institutions say adding more NHS staff by itself will not be enough to clear surgical backlogs, pointing to a deeper capacity problem inside the system.

Multiple reports say FDA Commissioner Marty Makary is expected to be fired, though the plans were described as not yet final. The prospect of a sudden leadership change is drawing attention to how quickly political moves

A new Medicare pilot would let some beneficiaries access GLP-1 weight-loss medicines for about $50 a month starting July 1, but the short-term design, eligibility rules, and prior authorization requirements leave major a

A large Medicare analysis found that primary care visit rates, access, and continuity all declined from 2017 to 2023, while telemedicine remained a relatively small share of care.

A new episode of STAT News’ Readout LOUD podcast centers on Seaport Therapeutics’ IPO, battles over obesity pills, and the political troubles surrounding FDA Commissioner Marty Makary.

Immigration attorneys say delays in a federal visa waiver program threaten to pull hundreds of foreign-trained physicians out of the U.S. just as they are due to begin work in shortage areas.

The first meeting of a federal autism committee centered on ‘profound autism,’ signaling where one strand of the policy discussion is likely to begin.

A newly reconstituted federal autism advisory committee used its first meeting to center the debated idea of ‘profound autism,’ highlighting how personnel changes are reshaping the government’s approach to autism policy.

Even without full detail in the supplied excerpt, the signal is clear: psychedelic treatments have moved closer to the center of US health policy discussion.

CMS has indefinitely delayed a Medicare pilot focused on obesity medication coverage after insurance plans signaled they were not ready to participate.

A new report says older men receiving federal housing assistance when diagnosed with prostate cancer had better two-year survival than similar patients without that support.

New research reports that reducing administrative burden in benefits applications can increase WIC application and enrollment rates.